声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。2月26日,科济药业发布公告,公司及若干附属公司与珠海横琴软银欣创股权投资管理企业(珠海软银欣创)旗下管理的基金达成协议。根据该等协议,珠海软银欣创同意以现金对价人民币8000万元认购优恺泽生物医药(上海)有限公司的新增注册资本,占优恺泽增资后注 册资本...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.